Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Family Offices Boost Life Sciences Partners’s Over-Subscribed Fifth Fund

Executive Summary

Family offices are increasing their exposure to Europe’s life sciences sector by investing in venture capital funds, including the just-closed over-subscribed fifth fund from Life Sciences Partners.

Advertisement

Related Content

VC Roundup: Three New Funds Close As Small, Early Financings Bounce Back
Forbion Closes Third Fund, 'Agnostic' On When To Invest
Big Pharma, UK Universities Launch 'Unique' Early Drug Development Fund
Abingworth Clinical Co-Development Fund 'Open For Business'
Bristol-Myers Squibb Makes First Investment In European VC Fund

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC065328

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel